2014, Number 1
Next >>
Ann Hepatol 2014; 13 (1)
Hepatology highlights
Aguilar-Olivos N, Méndez-Sánchez N
Language: English
References: 15
Page: 4-6
PDF size: 71.86 Kb.
ABSTRACT
No abstract.
REFERENCES
Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diab Care 2007; 30: 734-43.
Kobashi-Margáin RA, Gutiérrez-Grobe Y, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. Ann Hepatol 2010; 9: 282-8.
Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20(1 Pt. 1): 119-25.
Henning JR, Graffeo CS, Rehman A, Fallon NC, Zambirinis CP, Ochi A, Barilla R, et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology 2013; 58: 589-602.
Zimmermann, et al. Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis. PLoS ONE 2010; 5: e11049.
Global status report on noncommunicable diseases 2010. Geneva, World Health Organization; 2011.
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 1: CD004816.
De Denus S, Spinler SA, Miller K, et al. Statins and liver toxicity: a meta-analysis. Pharmacotherapy 2004; 24: 584-91.
Demyen M, Alkhalloufi K, Pyrsopoulos NT. Lipid-lowering agents and hepatotoxicity. Clin Liver Dis 2013; 17: 699- 714.
Cohen D, Anania F, Chalasani N. An assessment of statin safety by hepatolo-gists. Am J Cardiol 2006; 97: C77-C81.
Teschke R. Hepatotoxicity associated with statins. Ann Hepatol 2012; 11: 418-20.
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-2.
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-1273, e1261.
García-Samaniego J, Rodríguez M, Berenguer J, Rodríguez- Rosado R, Carbó J, Asensi V, Soriano V. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 179-83.
Kramer JR, Giordano TP, El-Serag HB. Effect of human immuno-deficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. Clin Gastroenterol Hepatol 2007; 5: 1321-8.
Full text